Hypolipidemic Drugs and Lipoprotein Metabolism
Insight into the mechanism of action and efficacy of hypolipidemic drugs has awaited the development of the current concepts of lipid transport (1). Fundamental is the fact that the blood fats-- cholesterol, phospholipid, and triglyceride-- do not circulate free in the plasma. Lipids exist in a soluble form in the blood only because they are bound to protein. These proteins serve as detergents and solubilize the otherwise insoluble lipid. It is as lipid protein complexes or lipoproteins that all fat enters and leaves the blood stream.
KeywordsNicotinic Acid Lipoprotein Metabolism Hepatic Cholesterol Synthetic Rate Hypolipidemic Drug
Unable to display preview. Download preview PDF.
- 2.Fredrickson, D. S. and R. T. Levy in The Metabolic Basis of Inherited Disease. (Eds.) J. B. Stanbury, J. B. Wyngaarden and D. S. Fredrickson, McGraw-Hill, New York, in press (1972)Google Scholar
- 4.Langer, T., W. Strober and R. I. Levy, in preparation.Google Scholar
- 6.Nosslin, B. in Metabolism of Human Gamma Globulin. (Ed.) S. B. Anderson, Blackwell Sci. Publ., Oxford (1964) p. 34.Google Scholar
- 11.Kritchevsky, D. in Proceedings of the Workshop on the Metabolic Effects of Nicotinic Acid, Flims. Switzerland (1970) in press.Google Scholar
- 13.Levy, R. I., D. Bilheimer and S. Eisenberg. Biochem. Soc. Symposium. In press (1972).Google Scholar
- 14.Langer, T., W. Strober and R. I. Levy. J. Clin. Invest. 48: 49a (1969).Google Scholar
- 15.Bilheimer, D. W., S. Eisenberg and R. I. Levy. A.H.A.Ahstract Circulation. Vol. 44: II - 56, 1971.Google Scholar